Clinical trial
NMDA-enhancing Agent for the Treatment of Mild Cognitive Impairment
NCT02239003 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NMDA-enhancing Agent for the Treatment of Mild Cognitive Impairment
- Lead sponsor
- Chang Gung Memorial Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- December 31, 2017
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mild cognitive impairment